GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OCSE:COLO B) » Definitions » Other Operating Expense

Coloplast A/S (OCSE:COLO B) Other Operating Expense : kr-31 Mil (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast A/S Other Operating Expense?

Coloplast A/S's Other Operating Expense for the three months ended in Mar. 2024 was kr-11 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-31 Mil.

Coloplast A/S's quarterly Other Operating Expense declined from Sep. 2023 (kr3 Mil) to Dec. 2023 (kr-16 Mil) but then increased from Dec. 2023 (kr-16 Mil) to Mar. 2024 (kr-11 Mil).

Coloplast A/S's annual Other Operating Expense declined from Sep. 2021 (kr-44 Mil) to Sep. 2022 (kr-49 Mil) but then increased from Sep. 2022 (kr-49 Mil) to Sep. 2023 (kr-22 Mil).


Coloplast A/S Other Operating Expense Historical Data

The historical data trend for Coloplast A/S's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Other Operating Expense Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58.00 -29.00 -44.00 -49.00 -22.00

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.00 -7.00 3.00 -16.00 -11.00

Coloplast A/S Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast A/S Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (OCSE:COLO B) Business Description

Traded in Other Exchanges
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (OCSE:COLO B) Headlines

No Headlines